Neoantigen Cancer Vaccine Market Analysis & Forecast Industry Growth 2025
The global Neoantigen Cancer Vaccine Market size was valued at USD XX Billion in 2021 and is projected to reach from USD XX Billion in 2022 to USD 1.38 Billion by 2030, growing at a CAGR of 76% during the forecast period (2022–2030). Neoantigen-based cancer vaccines are gaining significant attention as a transformative approach in cancer immunotherapy. These vaccines target personalized neoantigens, which are tumor-specific antigens that arise due to genetic mutations in cancer cells. With advancements in genomic technologies, the development of neoantigen cancer vaccines has seen substantial progress, particularly in tailoring treatments to individual patients, offering hope for effective cancer immunotherapy.